Deepika Garg, MD, FACOG
Assistant Professor of Obstetrics, Gynecology and Reproductive SciencesCards
About
Research
Publications
2022
Effect of chemotherapy on the uterus of young adult cancer survivors
Garg D, Hodgman M, Reil S, Lomo L, Aston K, Hill J, Johnstone E, Jenkins T, Letourneau J. Effect of chemotherapy on the uterus of young adult cancer survivors. F&S Reports 2022, 3: 198-203. PMID: 36212573, PMCID: PMC9532891, DOI: 10.1016/j.xfre.2022.05.008.Peer-Reviewed Original ResearchEndometrial thicknessChemotherapy exposureEndometrial biopsyUterine volumeCancer survivorsHodgkin's lymphomaMenstrual cycleDeoxyribonucleic acid (DNA) methylation patternsCross-sectional pilot studyYoung adult cancer survivorsImpact of chemotherapyRibonucleic acid expression levelsEffect of chemotherapyAdult cancer survivorsGeneral population controlsLate proliferative phaseMedian uterine volumeUniversity fertility clinicPelvic radiationEndometrial histologyPelvic ultrasoundCervical cancerFalse-positive resultsMenstruating womenStudy visit
2021
EFFECT OF ALKYLATING AGENT CHEMOTHERAPY ON THE UTERUS OF YOUNG ADULT CANCER SURVIVORS
Garg D, Jenkins T, Johnstone E, Aston K, Letourneau J. EFFECT OF ALKYLATING AGENT CHEMOTHERAPY ON THE UTERUS OF YOUNG ADULT CANCER SURVIVORS. Fertility And Sterility 2021, 116: e474. DOI: 10.1016/j.fertnstert.2021.08.028.Peer-Reviewed Original ResearchCancer treatment is associated with a measurable decrease in live births in a large, population-based study
Garg D, Meeks H, Johnstone E, Berga S, Smith K, Hotaling J, Letourneau J. Cancer treatment is associated with a measurable decrease in live births in a large, population-based study. F&S Reports 2021, 2: 462-467. PMID: 34934988, PMCID: PMC8655402, DOI: 10.1016/j.xfre.2021.08.004.Peer-Reviewed Original ResearchIncidence rate ratiosPopulation-based studyLive birth rateAge-matched controlsLive birthsCancer survivorsCancer typesHealthy controlsBreast cancerLower live birth ratesCancer treatmentCentral nervous system cancerRetrospective cohort studyFemale cancer patientsNon-cancer controlsNervous system cancersAge 18 yearsCommon cancer typesSoft tissue cancerBirth rateCohort studyGastrointestinal cancerCancer patientsSystem cancersMAIN OUTCOME
2020
LIKELIHOOD OF WOMEN ACHIEVING MORE THAN ONE LIVE BIRTH AFTER VARIOUS TYPES OF CANCERS
Garg D, Meeks H, Johnstone E, Berga S, Smith K, Hotaling J, Letourneau J. LIKELIHOOD OF WOMEN ACHIEVING MORE THAN ONE LIVE BIRTH AFTER VARIOUS TYPES OF CANCERS. Fertility And Sterility 2020, 114: e253. DOI: 10.1016/j.fertnstert.2020.10.012.Peer-Reviewed Original ResearchLooking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments
Garg D, Johnstone E, Lomo L, Fair D, Rosen M, Taylor R, Silver B, Letourneau J. Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments. Journal Of Assisted Reproduction And Genetics 2020, 37: 1467-1476. PMID: 32342270, PMCID: PMC7311602, DOI: 10.1007/s10815-020-01792-9.Peer-Reviewed Original ResearchConceptsCancer survivorsPregnancy complicationsObstetrical outcomesFertility-preserving treatmentLow birth weightPoor obstetrical outcomesFemale cancer survivorsImpact of chemotherapyEarly pregnancy lossOncofertility carePregnancy implantationLate complicationsPregnancy outcomesPreterm birthRadiation fibrosisEndometrial receptivityGonadotoxic effectsUterine injuryBirth weightPregnancy lossPregnant uterusBlood supplyUterine functionChemotherapyComplicationsMP26-10 PATERNAL CANCER HISTORY DOES NOT INCREASE OBSTETRIC COMPLICATIONS
Gross* K, Meeks H, Garg D, Patel D, Pastuszak A, Hanson H, Smith K, Letourneau J, Hotaling J. MP26-10 PATERNAL CANCER HISTORY DOES NOT INCREASE OBSTETRIC COMPLICATIONS. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000865.010.Peer-Reviewed Original ResearchMP26-09 MEN WITH CANCER DIAGNOSIS ARE OLDER AT TIME OF FIRST LIVE BIRTH:AN AGE-MATCHED COHORT ANALYSIS OF THE UTAH POPULATION DATABASE
Patel* D, Meeks H, Garg D, Gross K, Pastuszak A, Hanson H, Smith K, Letourneau J, Hotaling J. MP26-09 MEN WITH CANCER DIAGNOSIS ARE OLDER AT TIME OF FIRST LIVE BIRTH:AN AGE-MATCHED COHORT ANALYSIS OF THE UTAH POPULATION DATABASE. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000865.09.Peer-Reviewed Original ResearchPD25-06 MEN WITH PREVIOUS CANCER DIAGNOSIS HAVE LOWER PARITY: A CASE-CONTROL ANALYSIS OF THE UTAH POPULATION DATABASE
Gross* K, Meeks H, Garg D, Patel D, Pastuszak A, Hanson H, Smith K, Letourneau J, Hotaling J. PD25-06 MEN WITH PREVIOUS CANCER DIAGNOSIS HAVE LOWER PARITY: A CASE-CONTROL ANALYSIS OF THE UTAH POPULATION DATABASE. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000882.06.Peer-Reviewed Original ResearchTHE POTENTIAL IMPACT OF CANCER TREATMENT ON LIVE BIRTHS IN MEN AND WOMEN IN A LARGE POPULATION-BASED STUDY
Garg D, Meeks H, Johnstone E, Pastuszak A, Berga S, Smith K, Hotaling J, Letourneau J. THE POTENTIAL IMPACT OF CANCER TREATMENT ON LIVE BIRTHS IN MEN AND WOMEN IN A LARGE POPULATION-BASED STUDY. Fertility And Sterility 2020, 113: e4. DOI: 10.1016/j.fertnstert.2020.02.009.Peer-Reviewed Original ResearchChapter 1 Neuroendocrine mechanisms of reproduction
Garg D, Berga SL. Chapter 1 Neuroendocrine mechanisms of reproduction. Handbook Of Clinical Neurology 2020, 171: 3-23. PMID: 32736757, DOI: 10.1016/b978-0-444-64239-4.00001-1.Peer-Reviewed Original ResearchConceptsGnRH driveNeuroendocrinology of reproductionReproductive functionFunctional hypothalamic amenorrheaSex steroid hormone synthesisFollicle-stimulating hormoneGonadotropin-releasing hormoneStress-induced anovulationSteroid hormone synthesisAbsence of oocytesHypothalamic amenorrheaHypothalamic hypogonadismCongenital causesCeliac diseaseMenstrual cyclePsychogenic amenorrheaCommon causeGonadal axisEndocrine effectsAnterior pituitaryBrain tumorsBehavioral variablesSecondary insufficiencyAppropriate secretionNeuroendocrine mechanisms
Academic Achievements & Community Involvement
Clinical Care
Overview
Deepika Garg, MD, is a reproductive endocrinology and infertility (REI) specialist who provides individualized, compassionate care tailored to each patient’s goals and needs.
She approaches each patient with deep empathy and a personal commitment to their health care journey. She takes time to listen closely to their stories, understand their unique challenges, and build trust through compassionate, hands-on support every step of the way.
Dr. Garg works closely with patients to craft individualized treatment plans—ranging from intrauterine insemination (IUI) and in vitro fertilization (IVF) to fertility preservation and minimally invasive surgery—for diverse patients facing infertility, polycystic ovary syndrome (PCOS), endometriosis, or recurrent pregnancy loss.
Her patient-centered approach prioritizes evidence-based protocols and close monitoring to optimize outcomes, helping countless couples achieve successful pregnancies. “I blend medical expertise to turn dreams of family into reality,” she says, bringing cultural sensitivity to support every unique story.
Her lifelong passion for REI shines through in every patient interaction, turning medical expertise into deeply personal victories.
Clinical Specialties
Obstetrics, Gynecology & Reproductive Sciences; Reproductive Endocrinology & Infertility
Fact Sheets
Surrogacy
Learn More on Yale Medicine
Yale Medicine News
Links
Get In Touch
Contacts
Appointment Number
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.